Obagi Medical Sued by Investor Over $360 Million Offer

Obagi Medical Products Inc., which makes prescription-strength skin care systems, was sued by an investor seeking to block a $360 million acquisition by Valeant Pharmaceuticals International Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.